African Multinational Corporations are Catching Up
Africa is finally creating its own multinational corporations.
View ArticleMassachusetts AG Recommends Healthcare Price Controls
How can health care costs be controlled in Massachusetts? According to a June 22 report from the state’s Office of the Attorney General (OAG), the answer includes temporary controls on prices...
View ArticleAn Ounce of Prevention
Children in Malawi (Matthew Feldman) In our technology-laden world, it should come as no surprise that development wonks are constantly chasing the next “solution” to poverty. Though there are a few...
View ArticleGrowing Rwanda Out of Poverty
Steve Jones at his farm in Rwamagana, Rwanda. (Photo credit: Mary Robbins) For the last few years, development wonks and international organizations have had the “Green Revolution for Africa” on their...
View ArticleWhat If Doctors Could Finally Prescribe Behavior Change?
This guest article is by Sean Duffy, CEO and Co-Founder, Omada Health Three out of four Americans will die of a disease that could be avoided—if only they could re-route their unhealthy habits. A new...
View ArticleHow Silicon Valley Could Revolutionize Salinas Valley, America's Farming Capital
According to Norman Borlaug, in the next 40 years, farmers will have to grow as much food as they have in the last 10,000 years -- combined. Technology can make that achievable.
View ArticleWhy This 'Big Oil' CEO Believes In Applying A Price To Carbon
This guest article is by Ben van Beurden, CEO of Royal Dutch Shell Cutting greenhouse gas emissions while keeping the lights on for a growing global population is a huge but critical challenge. We have...
View ArticleMeet A Data Scientist Who's Helped Revolutionize Agriculture
Stanford professor David Lobell's pioneering work has opened eyes on the risks to food security from global warming, and now he's harnessing data to show how the agriculture sector can adapt.
View ArticleWhy Bankers, Financial Analysts And Doctors Need To Start Working Together
By the time the condominium association notified Renee Packel that she and her husband were months late paying their fee, Mr. Packel, who was in charge of the bill paying, had also made several...
View ArticleHow To Prepare For This Year's Open Enrollment Period
The fact is that, in 2016, consumers can expect big changes across insurers and across regions, with premiums on average increasing. But saying “on average” fails to tell the whole story.
View ArticleHow Health Benefits Are Driving Americans' Career Choices
From on-site fast food to relaxation lounges, it could be said we’re living in the era of the employee perk. But the work benefit to which employees pay most attention is healthcare.
View ArticleTo Help Employees Understand Health Benefits, Meet Them Where They Are
(Photo by George Frey/Getty Images) In my last post, I highlighted some findings from a recent study commissioned by my company, Collective Health. Our research showed that while most employees...
View ArticleIn Pursuit Of An HIV Vaccine And The AIDS-Free Generation
Shutterstock In the US, many people speak of “the AIDS crisis” as though it were something that happened and is now over. We do have effective treatments, and increasingly effective means of...
View ArticleHow You Can Help Make Clinical Trials Happen
In efforts to cure disease, researchers often encounter serious delays during a critical phase of the drug development process: clinical trials.
View ArticleIt Doesn't Matter That UnitedHealth Is Ditching Obamacare
Just because UnitedHealth hasn’t been successful in the individual market doesn’t mean the Affordable Care Act (ACA) has failed.
View ArticleWhy The World Needs An Essential Diagnostics List
Without diagnostics, medicine is blind. And yet, diagnostics receive much less attention than vaccines and drugs.
View ArticleYou Could Be Losing Healthcare Savings Due To A Government Mix-Up
A miscommunication between the IRS and Health & Human Services costs millions of Americans hundreds of dollars in healthcare savings every year.
View ArticleWhat The Debate Over Zika At The Olympics Ignores
A surprisingly low number of athletes and spectators will contract the Zika virus at the 2016 Rio Olympics. But that's not the whole story.
View ArticleDoctor: Even With Pneumonia, Clinton's Fainting Spell Looks Like A Routine...
We’ve all seen the video. Hillary Clinton is being assisted into a van by Secret Service agents. She stumbles, slumps, and appears to nearly faint. A sign of a serious illness? Probably not.
View ArticleBiotech CEOs: Don't Let EpiPen Threaten Innovation
The strong reaction to the behavior of Mylan and a few other companies is threatening to impede the ability of R&D-focused companies to provide innovative new therapies to patients.
View ArticleSimplifying Healthcare Is The Best Way To Take Care Of Workers
Rather than making it hard to be healthy, the workplace can be a place to promote health and get employees on the path to well-being.
View ArticleAlnylam CEO: Four Things To Learn From Medicine Development
As the CEO of Alnylam, my job has been to remove the roadblocks that so often bedevil efforts to turn good science into good medicine. And we’ve made incredible progress.
View ArticleWhy The Approach To Drug Pricing Has To Change Now
As an industry, we must shift to a model that focuses on value and outcomes delivered, both to patients and to health systems.
View ArticleWhy Pharma Needs To Invest In Discovery
The few bad actors who have dominated the headlines this year are not representative of the many companies across our industry that persist in investing in R&D, year after year, in the quest to...
View ArticleIt's Time to Disrupt the $3 Trillion Healthcare Industry
Only through an integrated healthcare ecosystem with changes in behaviors, data analytics, interoperability and aligning incentives can we disrupt healthcare for the better. The time to do so is now.
View ArticleAll Americans Must Benefit From The Golden Age Of Medicine
Academics, research institutions, private investors, government and the pharmaceutical industry have combined to produce a real golden age of medicine.
View ArticlePharma Needs To Have A Sense Of Urgency
Too many patients are still losing their battle with cancer. Specifically, we need to keep advancing the science, building on recent successes and making progress toward our ultimate goal: to turn...
View ArticleDoes A Trump Administration Equal Status Quo for Drug Pricing? Think Again
Companies doing the hard, long and risky work of bringing new medicines to market have generally understood that they have to price medicines in a way that makes them accessible to patients while...
View ArticleThe U.S. Government Should Buy Gilead For $156 Billion To Save Money On...
The U.S. government could cure most Americans suffering from hepatitis C infections if it simply bought drug maker Gilead Sciences on the stock market rather than purchasing its products in the drug...
View ArticleWhy Medical Schools Should Not Teach Integrative Medicine
Bogus medical treatments going under the name "integrative medicine" are making their way into leading medical schools.
View Article"Three Cups of Tea": Doing Good is Hard Work
The recent Greg Mortensen and "Three Cups of Tea" saga leaves a major lesson in its wake: doing well is hard work. All too often, not-for-profit leaders have their hearts in the work, but it all falls...
View ArticleWhy Is Abbott's TriLipix Defying Gravity?
Nobody knows whether Abbott's heart drugs actually improve the health of heart patients.
View ArticleBin Laden, Patriotism And Our Health Care Crisis
In the near-decade since the Sept. 11, 2001, terror attacks, the "War on Terror" has cost the United States about $1.3 trillion, according to the National Center on Defense Information. By comparison,...
View ArticleMeasles Invades The U.S. As The Anti-Vaccine Movement Scores Again
Measles is spreading in Utah, thanks to an unvaccinated middle school student who brought it back from Poland. We should tell unvaccinated citizens that they will have to be tested for diseases if they...
View ArticleWhy Improving Population Health Makes Financial Sense
When you think that only 10% of health outcomes are a result of the clinical care a person receives, you start thinking differently about what is needed to improve population health.
View ArticleHow The American Health Care Act Could Affect Digital Health
Although the future is uncertain, it's clear that industry experts all agree on one thing: digital innovation in healthcare will have an even greater impact in light of the changes ahead.
View ArticleWhat Precision Medicine Can Learn from the NFL
The world of cancer care is not moving nearly as fast as it could. Why? Misplaced competition.
View ArticleWhen It Comes To Healthcare Costs, New Medicines Are The Solution, Not The...
All healthcare stakeholders should work together to eliminate cost-sharing hurdles that may discriminate against patients who need care the most.
View ArticleWhy Medication Adherence Needs To Be A National Priority
For all the dizzying talk of repeal versus repair, one of the greatest cost drivers in healthcare is still hiding in plain sight.
View ArticleSen. Elizabeth Warren: Why CEOs Should Fight The Senate's Healthcare Bill
No family will escape the reach of the Republican repeal of our healthcare laws. And yet America’s CEOs look the other way.
View ArticleCAR-T Cell Therapy Is Here To Stay
After decades of research and development, we’re on the brink of a new era in the treatment of cancer, one where nearly every aspect—from the patient experience to the efficacy of treatments—may be...
View ArticlePfizer CEO: The Future Of American Innovation Rests On A Competitive U.S. Tax...
We want to build a future of innovation as rich as our history. A tax system that creates a level playing field for all companies will make the vision a reality.
View ArticleNovartis CEO: Here's How We Handled A Milestone In Pediatric Cancer
Immunotherapies are opening new ways to treat cancer, enabling us to target disease like never before and in cancers where progress has been elusive for years. Here, Novartis's chief executive explains...
View ArticleHow To Cure An Infectious Disease In The World's Poorest Countries
Gilead Sciences EVP Gregg Alton: Can lessons learned from HIV be applied to hepatitis C?
View ArticleNovartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs
Patients and the entire U.S. healthcare system deserve to benefit from biosimilars.
View ArticleAre Social Determinants The Missing Key To Improving Health?
As we think of clinical contributors to health, social determinants of health must become equally as important.
View ArticlePfizer CEO: How The Biopharmaceutical Industry Creates Value (And Jobs) For...
The most fundamental way in which the industry creates value is by discovering and manufacturing innovative medicines that help people live longer, healthier, more productive lives.
View ArticleRegeneron CEO & CSO: The Real Healthcare Problem Is Bigger Than You Think
We have grown increasingly concerned about the current dialogue on the biopharma industry, which tends to focus on short-term issues such as drug pricing, at the complete exclusion of much bigger...
View Article
